LNMG — Linike Medical Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Linike Medical, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2010 October 31st	2011 October 31st	R2012 October 31st	2013 October 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Net Income/Starting Line	0.034	-0.042	-0.057	-0.428
Depreciation
Changes in Working Capital	0.009	-0.008	0.057	0.399
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	0.044	-0.048	-0	-0.028
Capital Expenditures	-0.007	0	—	—
Purchase of Fixed Assets
Cash from Investing Activities	-0.007	0	—	—
Financing Cash Flow Items	0.004	-0.012	0	0.016
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Cash from Financing Activities	0.004	0.107	0.002	0.016
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.041	0.058	0.002	0.001